Delivery Order SPE2DB22D1202-SPE2DB25FVGG0
- Not listed
- The Defense Logistics Agency awarded a $44,543.69 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a $10,027.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. The contract, with an ultimate completion date of August 8, 2025, represents a pharmaceutical delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order is not set-aside and was competitively awarded. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $34,386.90 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This firm fixed price, competitively awarded delivery order was issued on July 25, 2025, with an ultimate completion date of July 28, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child contract under the company's larger Indefinite...
- The Defense Logistics Agency awarded a $20,861.79 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price contract with no set-aside designation, competitively awarded to support federal pharmaceutical procurement needs. The work is scheduled for completion by August 1, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $20,176.14 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 30, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. The contract contains no set-aside designation, reflecting AmerisourceBergen's qualification to compete in open federal procurement....
- The Defense Logistics Agency awarded a delivery order valued at $16,346.38 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of August 12, 2025, and performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the vendor's proven...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supply on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract, valued at $3,835.11 under a firm fixed-price arrangement, covers the delivery of Descovy 200-25 mg tablets in quantities of 30 units. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Descovy 200-25 mg tablets in a 30-count unit configuration, valued at $8,022.27. This firm fixed price delivery order was competitively awarded with no set-aside designation and is scheduled for completion by July 22, 2025. The contract reflects AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and veteran healthcare systems, with performance occurring at the company's...
- The Defense Logistics Agency awarded a $37,229.95 firm fixed price delivery order to AmerisourceBergen Drug Corp for Descovy 200-25 mg tablets (30-count units) with an ultimate completion date of August 8, 2025. This non-set-aside contract was competitively awarded and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units, with a contract ceiling value of $21,872.95. This competitively awarded, firm fixed-price delivery order is set to be completed by July 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVGG0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,539.97 to AmerisourceBergen Drug Corp for supply of Descovy 200-25 mg tablets (30-count units). This non-competitive, firm fixed-price delivery order was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. As a child contract under the SPE2DX vehicle, this delivery order reflects AmerisourceBergen's role as a critical pharmaceutical supplier to the Department of Defense medical supply chain. The SPE2DX prime IDC serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a wide range of medications, vaccines, and medical supplies to military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's federal contract portfolio demonstrates its capability to efficiently fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains through competitively awarded, firm fixed-price delivery mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 8/1/25 |